HNF1A and non-small cell lung carcinoma: Further online database (https://kmplot.com/analysis/) survival analysis showed that patients with high HNF1A expression among NSCLC patients receiving chemotherapy had poorer post-progression survival, suggesting that HNF1A expression was a reliable marker of chemotherapy efficacy in NSCLC patients (Fig. 8h).